Trial Profile
Effect of Repeated Administration of Eslicarbazepine Acetate (BIA 2-093) 800mg Once-Daily on the Pharmacokinetics of a Combined Oral Contraceptive in Healthy Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Dec 2014
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Partial epilepsies; Pregnancy
- Focus Pharmacokinetics
- Sponsors Bial
- 14 May 2009 New trial record